Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pannacean
Zhengzhou, Henan, Chinaen.pannacean.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Pannacean specializes in the research, development, and supply of active pharmaceutical ingredients (APIs), drug metabolites, key intermediates, innovative nucleosides, phosphoramidite monomers for oligonucleotide/RNA synthesis, and related substances[1][2]. The company supports partners in small molecule and biomolecule drug development by providing high-quality building blocks but does not have its own clinical pipeline.
- Modalities
- Small moleculeNucleoside analogsOligonucleotide monomersRNA-based drugs (enabling technology)
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Pannacean.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pannacean.